The Danish national guidelines for treatment of oral squamous cell carcinoma

Anders Bilde; Christian von Buchwald; Jørgen Johansen; Lars Bastholt; Jens A H M Sørensen; Peter Marker; Annelise Krogdahl; Hanne Sand Hansen; Lena Specht; Jørgen Kirkegaard; Elo Andersen; Jens Bentzen; Christian Hjort-Sørensen; Lisbeth Juhler Andersen; Bengt Agathon Nielsen; Troels Bundgaard; Marie Overgaard; Cai Grau; Danish Society for Head and Neck Oncology

doi:10.1080/02841860600592998

The Danish national guidelines for treatment of oral squamous cell carcinoma

Anders Bilde, Christian von Buchwald, Jørgen Johansen, Lars Bastholt, Jens A H M Sørensen, Peter Marker, Annelise Krogdahl, Hanne Sand Hansen, Lena Specht, Jørgen Kirkegaard, Elo Andersen, Jens Bentzen, Christian Hjort-Sørensen, Lisbeth Juhler Andersen, Bengt Agathon Nielsen, Troels Bundgaard, Marie Overgaard, Cai Grau, Danish Society for Head and Neck Oncology

Department of Clinical Medicine

27 Citations (Scopus)

Abstract

The treatment strategy for oral squamous cell carcinoma in Denmark has traditionally varied between the different head and neck oncology centres. A study group within the Danish Society for Head and Neck Oncology (DSHHO) was formed with the aim of optimising and standardising the treatment strategy. The approach was to use single modality treatment for stage I, stage II and some stage III and combined modality treatment for stage III and IV. Surgery was the preferred treatment when it was considered possible to perform a radical excision of the tumour and possible lymph node metastases with acceptable aesthetic and functional outcome. The implementation of a recognised national guideline facilitates prospective studies on a large well-characterised cohort. This increases the possibility of obtaining valid data on parameters such as morbidity, loco-regional control and survival. In addition the establishment of a reference program facilitates national monitoring of the treatment using defined indicators and standards.

Original language	English
Journal	Acta Oncologica
Volume	45
Issue number	3
Pages (from-to)	294-9
Number of pages	6
ISSN	0284-186X
DOIs	https://doi.org/10.1080/02841860600592998
Publication status	Published - 2006

Access to Document

10.1080/02841860600592998

Cite this

Bilde, A., von Buchwald, C., Johansen, J., Bastholt, L., Sørensen, J. A. H. M., Marker, P., Krogdahl, A., Hansen, H. S., Specht, L., Kirkegaard, J., Andersen, E., Bentzen, J., Hjort-Sørensen, C., Andersen, L. J., Nielsen, B. A., Bundgaard, T., Overgaard, M., Grau, C., & Danish Society for Head and Neck Oncology (2006). The Danish national guidelines for treatment of oral squamous cell carcinoma. Acta Oncologica, 45(3), 294-9. https://doi.org/10.1080/02841860600592998

Bilde, A, von Buchwald, C, Johansen, J, Bastholt, L, Sørensen, JAHM, Marker, P, Krogdahl, A, Hansen, HS, Specht, L, Kirkegaard, J, Andersen, E, Bentzen, J, Hjort-Sørensen, C, Andersen, LJ, Nielsen, BA, Bundgaard, T, Overgaard, M, Grau, C & Danish Society for Head and Neck Oncology 2006, 'The Danish national guidelines for treatment of oral squamous cell carcinoma', Acta Oncologica, vol. 45, no. 3, pp. 294-9. https://doi.org/10.1080/02841860600592998

@article{5a4473b04c7e11df928f000ea68e967b,

title = "The Danish national guidelines for treatment of oral squamous cell carcinoma",

abstract = "The treatment strategy for oral squamous cell carcinoma in Denmark has traditionally varied between the different head and neck oncology centres. A study group within the Danish Society for Head and Neck Oncology (DSHHO) was formed with the aim of optimising and standardising the treatment strategy. The approach was to use single modality treatment for stage I, stage II and some stage III and combined modality treatment for stage III and IV. Surgery was the preferred treatment when it was considered possible to perform a radical excision of the tumour and possible lymph node metastases with acceptable aesthetic and functional outcome. The implementation of a recognised national guideline facilitates prospective studies on a large well-characterised cohort. This increases the possibility of obtaining valid data on parameters such as morbidity, loco-regional control and survival. In addition the establishment of a reference program facilitates national monitoring of the treatment using defined indicators and standards.",

author = "Anders Bilde and {von Buchwald}, Christian and J{\o}rgen Johansen and Lars Bastholt and S{\o}rensen, {Jens A H M} and Peter Marker and Annelise Krogdahl and Hansen, {Hanne Sand} and Lena Specht and J{\o}rgen Kirkegaard and Elo Andersen and Jens Bentzen and Christian Hjort-S{\o}rensen and Andersen, {Lisbeth Juhler} and Nielsen, {Bengt Agathon} and Troels Bundgaard and Marie Overgaard and Cai Grau and {Danish Society for Head and Neck Oncology}",

note = "Keywords: Carcinoma, Squamous Cell; Denmark; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Radiotherapy; Societies, Medical",

year = "2006",

doi = "10.1080/02841860600592998",

language = "English",

volume = "45",

pages = "294--9",

journal = "Acta Oncologica, Supplement",

issn = "1100-1704",

publisher = "Taylor & Francis",

number = "3",

}

TY - JOUR

T1 - The Danish national guidelines for treatment of oral squamous cell carcinoma

AU - Bilde, Anders

AU - von Buchwald, Christian

AU - Johansen, Jørgen

AU - Bastholt, Lars

AU - Sørensen, Jens A H M

AU - Marker, Peter

AU - Krogdahl, Annelise

AU - Hansen, Hanne Sand

AU - Specht, Lena

AU - Kirkegaard, Jørgen

AU - Andersen, Elo

AU - Bentzen, Jens

AU - Hjort-Sørensen, Christian

AU - Andersen, Lisbeth Juhler

AU - Nielsen, Bengt Agathon

AU - Bundgaard, Troels

AU - Overgaard, Marie

AU - Grau, Cai

AU - Danish Society for Head and Neck Oncology

N1 - Keywords: Carcinoma, Squamous Cell; Denmark; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Radiotherapy; Societies, Medical

PY - 2006

Y1 - 2006

N2 - The treatment strategy for oral squamous cell carcinoma in Denmark has traditionally varied between the different head and neck oncology centres. A study group within the Danish Society for Head and Neck Oncology (DSHHO) was formed with the aim of optimising and standardising the treatment strategy. The approach was to use single modality treatment for stage I, stage II and some stage III and combined modality treatment for stage III and IV. Surgery was the preferred treatment when it was considered possible to perform a radical excision of the tumour and possible lymph node metastases with acceptable aesthetic and functional outcome. The implementation of a recognised national guideline facilitates prospective studies on a large well-characterised cohort. This increases the possibility of obtaining valid data on parameters such as morbidity, loco-regional control and survival. In addition the establishment of a reference program facilitates national monitoring of the treatment using defined indicators and standards.

AB - The treatment strategy for oral squamous cell carcinoma in Denmark has traditionally varied between the different head and neck oncology centres. A study group within the Danish Society for Head and Neck Oncology (DSHHO) was formed with the aim of optimising and standardising the treatment strategy. The approach was to use single modality treatment for stage I, stage II and some stage III and combined modality treatment for stage III and IV. Surgery was the preferred treatment when it was considered possible to perform a radical excision of the tumour and possible lymph node metastases with acceptable aesthetic and functional outcome. The implementation of a recognised national guideline facilitates prospective studies on a large well-characterised cohort. This increases the possibility of obtaining valid data on parameters such as morbidity, loco-regional control and survival. In addition the establishment of a reference program facilitates national monitoring of the treatment using defined indicators and standards.

U2 - 10.1080/02841860600592998

DO - 10.1080/02841860600592998

M3 - Journal article

C2 - 16644572

SN - 1100-1704

VL - 45

SP - 294

EP - 299

JO - Acta Oncologica, Supplement

JF - Acta Oncologica, Supplement

IS - 3

ER -

The Danish national guidelines for treatment of oral squamous cell carcinoma

Abstract

Access to Document

Fingerprint

Cite this